QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that President and CEO Eamonn Hobbs will participate in a panel discussion on “Poking Around the Cath Lab: Bringing Innovation To Cardiovascular Disease” at the 2007 RBC Capital Markets Healthcare Conference on Wednesday, December 12, 2007 at 11:00 a.m. Eastern Time in The Westin New York at Times Square in New York.
